Search research articles
Contact Us
Filters
Showing results (21-30 of 167) with videos related to
Page
of 17
Sort By:
Scientific Reports
|
March 19, 2015
IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection
Kristian Tonby, Morten Ruhwald, Dag Kvale, et al.
Respirology (Carlton, Vic.)
|
November 30, 2012
Point-of-care diagnosis of tuberculosis: past, present and future
Keertan Dheda, Morten Ruhwald, Grant Theron, et al.
Scientific Reports
|
June 8, 2017
Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis
Christina Jensen, Line Lindebo Holm, Erik Svensson, et al.
Scientific Reports
|
March 29, 2024
Author Correction: Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis
Christina Jensen, Line Lindebo Holm, Erik Svensson, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 21, 2007
Correlates for disease progression and prognosis during concurrent HIV/TB infection
Joel Fleury Djoba Siawaya, Morten Ruhwald, Jesper Eugen-Olsen, et al.
The European Respiratory Journal
|
December 7, 2013
Beyond the IFN-γ horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis
Novel N Chegou, Jan Heyckendorf, Gerhard Walzl, et al.
The Journal of Infectious Diseases
|
March 20, 2019
KLRG1-Expressing CD4 T Cells Are Reduced in Tuberculosis Patients Compared to Healthy Mycobacterium tuberculosis-Infected Subjects, but Increase With Treatment
Kristian Tonby, Rasmus Mortensen, Morten Ruhwald, et al.
BMC Research Notes
|
February 6, 2009
IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay
Morten Ruhwald, Morten Bjerregaard-Andersen, Paulo Rabna, et al.
The Lancet. Global Health
|
February 5, 2022
Considerations for simultaneous testing of COVID-19 and tuberculosis in high-burden countries
Morten Ruhwald, Emma Hannay, Sanjay Sarin, et al.
BMJ Paediatrics Open
|
September 2, 2022
FujiLAM for the diagnosis of childhood tuberculosis: a systematic review
Laura Olbrich, Nisreen Khambati, Else Margreet Bijker, et al.
Page
of 17
Search research articles
Search
Showing results (21-30 of 167) with videos related to
Sort By:
Page
of 17
Scientific Reports
|
March 19, 2015
IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection
Kristian Tonby, Morten Ruhwald, Dag Kvale, et al.
Respirology (Carlton, Vic.)
|
November 30, 2012
Point-of-care diagnosis of tuberculosis: past, present and future
Keertan Dheda, Morten Ruhwald, Grant Theron, et al.
Scientific Reports
|
June 8, 2017
Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis
Christina Jensen, Line Lindebo Holm, Erik Svensson, et al.
Scientific Reports
|
March 29, 2024
Author Correction: Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis
Christina Jensen, Line Lindebo Holm, Erik Svensson, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 21, 2007
Correlates for disease progression and prognosis during concurrent HIV/TB infection
Joel Fleury Djoba Siawaya, Morten Ruhwald, Jesper Eugen-Olsen, et al.
The European Respiratory Journal
|
December 7, 2013
Beyond the IFN-γ horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis
Novel N Chegou, Jan Heyckendorf, Gerhard Walzl, et al.
The Journal of Infectious Diseases
|
March 20, 2019
KLRG1-Expressing CD4 T Cells Are Reduced in Tuberculosis Patients Compared to Healthy Mycobacterium tuberculosis-Infected Subjects, but Increase With Treatment
Kristian Tonby, Rasmus Mortensen, Morten Ruhwald, et al.
BMC Research Notes
|
February 6, 2009
IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay
Morten Ruhwald, Morten Bjerregaard-Andersen, Paulo Rabna, et al.
The Lancet. Global Health
|
February 5, 2022
Considerations for simultaneous testing of COVID-19 and tuberculosis in high-burden countries
Morten Ruhwald, Emma Hannay, Sanjay Sarin, et al.
BMJ Paediatrics Open
|
September 2, 2022
FujiLAM for the diagnosis of childhood tuberculosis: a systematic review
Laura Olbrich, Nisreen Khambati, Else Margreet Bijker, et al.
Page
of 17